Targeting Noncanonical Nuclear Factor Kappa B Signaling in CYLD Cutaneous Syndrome by Selective Inhibition of IκB Kinase Alpha

    June 2026 in “ Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) ”
    Kirsty Hodgson, Joseph Inns, Gary Reynolds … Neil Rajan
    Studysummary In this study, researchers found that inhibiting IKKα in patient-derived CCS tumour models reduces tumour viability, supporting the potential for topical IKKα inhibitors as a treatment for CCS.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on strathprints.strath.ac.uk →
    Discuss this study in the Community →